Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 400MG | 0 | VYVGART | EFGARTIGIMOD ALFA |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2021-12-17 | STANDARD |
Submissions Property Types
CDER Filings
ARGENX BV
cder:Array
(
[0] => Array
(
[ApplNo] => 761195
[companyName] => ARGENX BV
[docInserts] => ["",""]
[products] => [{"drugName":"VYVGART","activeIngredients":"EFGARTIGIMOD ALFA","strength":"400MG","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"12\/17\/2021","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/761195s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"12\/17\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/761195s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/761195Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2021-12-17
)
)